Finance

Beta
Lists
RYTM:NASDAQ
Rhythm Pharmaceuticals Inc
$108.26
+0.66%
(+0.71) 1D
$108.26
0.00% (0.00)
After hours
Closed: Jun 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RYTM...
Open
$107.19
High
$111.71
Low
$106.02
Mkt. cap
7.42B
Avg. vol.
787.05K
Volume
406.00
52-wk high
$122.20
52-wk low
$60.80
EPS
-$3.14
Beta
1.92
Shares outstanding
68.59M
No. of employees
414
Open
$107.19
High
$111.71
Low
$106.02
Mkt. cap
7.42B
Avg. vol.
787.05K
Volume
406.00
52-wk high
$122.20
52-wk low
$60.80
EPS
-$3.14
Beta
1.92
Shares outstanding
68.59M
No. of employees
414
News stories
From sources across the web
About Rhythm Pharmaceuticals Inc
CEO-
Employees414
FoundedNov 2008
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websiterhythmtx.com
Analyst ratings
Based on 12 analysts giving stock ratings to RYTM in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for RYTM in the last 3 months.
Highest
Current $108.26
$159.00 (+46.87%)
Average
$137.75 (+27.24%)
Lowest
$105.00 (-3.01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Phil Nadeau
TD Cowen
Buy
Maintained
$130.00
+20.1%
06/17/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$151.00
+39.5%
06/16/2026
Dennis Ding
Jefferies
Buy
Maintained
$125.00
+15.5%
06/15/2026
Corinne Johnson
Goldman Sachs
Buy
Maintained
$159.00
+46.9%
06/14/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
$136.00
+25.6%
06/14/2026
Tazeen Ahmad
Bank of America Securities
Buy
Maintained
$149.00
+37.6%
06/15/2026
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
$133.00
+22.9%
06/15/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
$143.00
+32.1%
06/15/2026
Joseph Stringer
Needham
Buy
Maintained
$130.00
+20.1%
06/15/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$155.00
+43.2%
06/17/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$105.00
-3%
06/15/2026
Lisa Walter
RBC Capital
Buy
Maintained
$137.00
+26.5%
05/05/2026
Samantha Semenkow
Citi
Buy
Reiterated
$142.00
+31.2%
03/20/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$152.00
+40.4%
03/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
48.50M
51.30M
57.25M
60.11M
Cost of goods sold
5.54M
5.50M
4.80M
7.16M
Cost of revenue
5.54M
5.50M
4.80M
7.16M
Research and development expenses
42.31M
46.03M
42.03M
41.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45.95M
52.42M
57.48M
63.59M
Operating expense
88.26M
98.45M
99.51M
105.32M
Total operating expenses
93.80M
103.95M
104.32M
112.47M
Operating income
-45.30M
-52.65M
-47.06M
-52.36M
Other non operating income
1.58M
274.00K
57.00K
-3.10M
EBT including unusual items
-46.30M
-52.79M
-47.54M
-55.09M
EBT excluding unusual items
-46.30M
-52.79M
-47.54M
-55.09M
Income tax expense
337.00K
111.00K
-31.00K
545.00K
Effective tax rate
-0.73%
-0.21%
0.07%
-0.99%
Other operating expenses
-
-
-
-
Net income
-46.63M
-52.90M
-47.50M
-55.64M
Net profit margin
-96.14%
-103.13%
-82.97%
-92.56%
Earnings per share
-0.75
-0.82
-0.73
-0.83
Interest and investment income
3.24M
4.33M
4.08M
3.55M
Interest expense
-5.82M
-4.74M
-4.62M
-4.58M
Net interest expenses
-2.58M
-414.00K
-530.00K
-1.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.92M
-52.35M
-46.79M
-52.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of RYTM
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer